Maccare Super specialty Hospital
Zopadi Canteen Near Opp Saint Monica D.Ed College,Savedi, Ahmednagar,Maharashtra , 414003. India
PI Name:-Dr.Satish Sonawane.(MBBS,MS,Oncosurgon)
CO-I : Dr.Bhushan Nikam (Radiation Oncologist)
Below Mentioned Study Ongoing on Maccare Superspeciality Hospital Ahmednagar.
“A Phase 2a, Multi-center, Open Label, Dose Optimization, Pilot Study to Assess the Safety and Tolerability at the Maximum Tolerated Dose of Parenteral TK-112690 in Non- Metastatic Squamous CellCarcinoma of Head and Neck Patients Scheduled to Receive Chemoradiation.”
A multi-center, open-label, balanced, randomized, two-treatment, two-period, twosequence,two-way crossover, multiple-dose, steady-state bioequivalence study of Pazopanib HCl Tablets 200mg (4 Tablets X 200 mg) of MSN Laboratories Private Limited, India compared with Votrient® Tablet200mg (4 Tablets X 200 mg) of Novartis Pharmaceuticals Corporation, USA in Advanced renal cellcarcinoma patients who are already receiving Pazopanib HCl tablets in standard therapy, and who are tolerating a stable dosing regimen of 800 mg/day under fasting conditions.
An Open-Label, Single Dose, Multicenter, Randomized, Partial Replicate, Cross-Over, Bioequivalence study of Leuprolide Acetate for Depot Suspension 7.5mg for 1- Month administration of Pharmathen S.A. with Leupron Depot 7.5mg for 1-Month administration for Intramuscular Injection in Adult Male Patients with Prostate Carcinoma undergoing Initial Therapy of Leuprolide Acetate.
